Showing results (1431-1440 of 1,485) with videos related to
Sort By:
Pageof 149
Regenerative Biomaterials|April 28, 2022
3D printed collagen/silk fibroin scaffolds carrying the secretome of human umbilical mesenchymal stem cells ameliorated neurological dysfunction after spinal cord injury in ratsChong Chen, Hai-Huan Xu, Xiao-Yin Liu, et al.Fitoterapia|September 24, 2018
LC-MS guided isolation of gracilistones A and B, a pair of diastereomeric sesquiterpenoids with an unusual tetrahydrofuran-fused tricyclic skeleton from Acanthopanax gracilistylus and their potential anti-inflammatory activitiesHong-Bo Xu, Tong-Hua Yang, Pei Xie, et al.Neuro-Oncology|September 12, 2014
VAMP8 facilitates cellular proliferation and temozolomide resistance in human glioma cellsYuanyuan Chen, Delong Meng, Huibo Wang, et al.Cell Reports|October 2, 2025
m6A-mediated circG3BP1 translocation to stress granules promotes nucleation and senescence-linked chemoresistanceRi-Xin Chen, Ao-Tian Mo, Shui-Dan Xu, et al.World Journal of Oncology|September 21, 2022
Pathological Responses of the Primary Tumor and Locoregional Lymph Nodes After Neoadjuvant Immunochemotherapy in Esophageal Squamous Cell CancerShu Jie Huang, Dan Tian, Si Chao Wang, et al.The Journal of Clinical Investigation|April 25, 2024
RNA splicing analysis deciphers developmental hierarchies and reveals therapeutic targets in adult gliomaXiao Song, Deanna Tiek, Shunichiro Miki, et al.Cell Research|August 19, 2017
5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stagesChun-Xiao Song, Senlin Yin, Li Ma, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 12, 2026
NIPAL1 Drives a Metabolic-Epigenetic Feedback Loop to Promote Lactate-Mediated Immune Evasion in Esophageal CancerRi-Xin Chen, Xiao-Dan Ma, Shui-Dan Xu, et al.Current Research in Chemical Biology|November 27, 2023
SGC-CLK-1: A chemical probe for the Cdc2-like kinases CLK1, CLK2, and CLK4Deanna Tiek, Carrow I Wells, Martin Schröder, et al.Science Advances|July 4, 2025
Safety and immunogenicity of intranasal parainfluenza virus type 5 (PIV5)-vectored COVID-19 vaccine in adults and teens in an open-label phase 1 trialPaul Spearman, Hong Jin, Peng Xiao, et al.Pageof 149